Clinical trial NCT06611800: Personalized Advance Prescriptions in Palliative Care at HOME: Interests and Difficulties of Its Implementation
Official title: Personalized Advance Prescriptions in Palliative Care at HOME: Interests and Difficulties of Its Implementation (PAPHOME)
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Palliative Care
Lead sponsor: Centre Hospitalier William Morey - Chalon sur Saône
Sponsor class: OTHER
First posted: 2024-09-25
Enrollment: 256
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: RETROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients over the age of 18 cared for by the mobile palliative care team at the William Morey Hospital Center in Chalon sur Saône, who died between 01/01/2022 and 12/31/2022, having been cared for at least once in their place of life (home, EHPAD) with a visit or a call to the attending physician for advice

Brief summary: Retrospective data collection on the files of patients cared for by the mobile palliative care team of the William Morey Hospital Center who died in 2022.

Detailed description: Retrospective selection of patients and collection of data : pathology, identified risk, presence of caregiver, end-of-life wishes, characteristics of palliative care treatment, circumstances of death. Comparison of two groups : presence or absence of personalized advance prescriptions.

Eligibility criteria: Inclusion Criteria:

* Minimum 18 years old
* Taken care of once in their place of life by a palliative care team
* Died between 01/01/2022 and 12/31/2022 in William Morey Hospital Center

Exclusion Criteria: none

Primary outcomes:
measure: Know if the presence of advance prescriptions can lead to a reduction in the number of emergency admissions for an "avoidable reason" by its management by a mobile palliative care team (with a maximum of 6 months before death)
timeFrame: A year
Secondary outcomes:
measure: Reduction in the number of emergency admissions for all reasons in their last 6 months of life.
timeFrame: A year
measure: Describe conditions of death: location, respect for the wishes of a death at home and notion of a calm death collected from the family
timeFrame: A year
measure: Describe the treatments used for PAPs: Analgesics, Anxiolytics, Anti-secretory drugs, Neuroleptics, Anti-histamines, Anti-emetics
timeFrame: A year
Other outcomes:
Locations:
city: Chalon sur Saône
country: France
facility: CH William Morey
Study officials:
affiliation: Centre Hospitalier William Morey
name: Julie COLLOT
role: PRINCIPAL_INVESTIGATOR
References:
citation: Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010 Aug 19;363(8):733-42. doi: 10.1056/NEJMoa1000678.
citation: Haun MW, Estel S, Rucker G, Friederich HC, Villalobos M, Thomas M, Hartmann M. Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev. 2017 Jun 12;6(6):CD011129. doi: 10.1002/14651858.CD011129.pub2.